DNLI
Denali Therapeutics Inc
20.50$
-0.7%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -79.3% | +1,158.2% | -85.5% | +122.9% | +204.7% | -100.0% | – | |
| – | +1,114.0% | +4,968.8% | +92.3% | +35.1% | +9.9% | -97.4% | +25.4% | +137.9% | -53.4% | +43.5% | |
| – | – | – | – | -79.3% | +1,158.2% | -85.5% | +122.9% | +204.7% | -102.4% | – | |
| – | +554.2% | -1.6% | +92.3% | +35.1% | +9.9% | +24.8% | +35.2% | +18.2% | -6.5% | +5.6% | |
| – | +129.7% | +33.7% | +106.3% | +43.7% | +29.8% | +31.1% | +14.4% | +14.2% | +2.0% | -7.9% | |
| – | +424.2% | +3.1% | +94.7% | +36.6% | +13.8% | +26.2% | +30.4% | +17.4% | -7.6% | +11.7% | |
| – | – | – | – | – | – | -571.6% | – | – | – | – | |
| – | -100.0% | – | +0.0% | +678.5% | +16.8% | -25.8% | +12.0% | – | – | – | |
| – | – | – | – | – | – | -504.6% | – | – | – | – | |
| – | – | – | – | -103.5% | – | -169.9% | – | +42.9% | +126.7% | +50.0% | |
| – | – | – | – | – | – | -508.5% | – | – | – | – | |
| – | – | – | – | – | – | -503.0% | – | – | – | – |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.